Electrical Stimulation for Improving Postoperative Breast Sensation
Launched by UNIVERSITY OF ALBERTA · Aug 4, 2017
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether electrical stimulation (ES) can help improve sensation in the breast after surgery for women who are at high risk for breast cancer. Many women choose to undergo preventive mastectomy, which involves removing breast tissue to reduce their chances of developing cancer. A common issue after this type of surgery is that women often lose feeling in their new breasts, which can lead to discomfort and even safety concerns. The researchers believe that using ES during the reconstruction process might help nerves heal and restore some of this lost sensation.
To participate in the trial, women aged 18 to 60 who are planning to have a specific type of breast surgery called bilateral nipple/skin-sparing mastectomy with immediate implant reconstruction may be eligible. During the surgery, one breast will receive ES while the other will not, allowing researchers to compare the results. After the procedure, the team will regularly check how well sensation returns over two years. Participants will also complete a survey about their feelings and sensations. It's important to note that women who smoke, have certain nerve conditions, or have had previous breast surgeries cannot participate in this study.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Woman aged 18-60 undergoing bilateral, prophylactic nipple/skin-sparing mastectomy with immediate implant reconstruction
- Exclusion Criteria:
- • Smokers
- • Preexisting peripheral neuropathy
- • Prior breast surgery
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Edmonton, Alberta, Canada
Patients applied
Trial Officials
Ming Chan
Principal Investigator
Professor University of Alberta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials